This confirmed the role of CXCR4 in the ABC but not the GCB subtype of DLBCL, suggesting that CXCR4 exerts an adverse effect on the prognosis of the ABC subtype DLBCL through the above molecular signaling pathways. The gene discussed is CXCR4; the disease is diffuse large B-cell lymphoma.